Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations

v3.21.2
Condensed Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Revenue:        
Total revenue $ 1,363,037 $ 219,585 $ 2,770,202 $ 490,372
Revenue from Contract with Customer, Product and Service [Extensible List] us-gaap:GrantMember us-gaap:GrantMember us-gaap:GrantMember us-gaap:GrantMember
Costs and expenses:        
Research and development $ 2,382,433 $ 263,175 $ 4,814,293 $ 546,289
Selling, general and administrative 1,608,972 370,331 3,209,548 898,019
Total costs and expenses 3,991,405 633,506 8,023,841 1,444,308
Loss from operations (2,628,368) (413,921) (5,253,639) (953,936)
Interest expense (7,811) (7,948) (19,608) (15,373)
Net loss $ (2,636,179) $ (421,869) $ (5,273,247) $ (969,309)
Net loss per share – basic and diluted $ (0.22) $ (0.05) $ (0.47) $ (0.12)
Weighted-average number of common shares – basic and diluted 12,241,935 8,181,938 11,153,986 8,181,836